Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

NCT04080635 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

PROCEDURE: Venapuncture
OTHER: Patient questionnaires

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]